Endometriosis: the role of neuroangiogenesis.
Level 5 - mechanism / opinion, no new human data
Narrative review of biological mechanisms and therapeutic concepts without systematic synthesis or primary human data.
PubMed 21054165 · doi:10.1146/annurev-physiol-012110-142158
What was done
This narrative review summarizes evidence on the pathophysiology of endometriosis, focusing on chronic peritoneal inflammation, the recruitment of vascular and neural networks (neuroangiogenesis) within ectopic implants, and the mechanisms driving pelvic pain to explore novel therapeutic targets.
What was found
The abstract reports that endometriosis affects approximately 10% of reproductive-age women and incurs over $20 billion in annual healthcare costs in the United States. Ectopic lesions generate localized inflammation with elevated prostaglandins, cytokines, and growth factors, and establish dedicated nerve and vascular supplies through neuroangiogenesis. These nascent nerve fibers are thought to stimulate dorsal root neurons to heighten central pain perception. No specific experimental metrics, quantitative effect estimates, or primary trial numbers are reported in the abstract.
Why it matters
Targeting neuroangiogenesis in endometriotic lesions may offer non-hormonal and non-surgical avenues for pain relief, potentially bypassing the adverse effects of hypoestrogenism and surgical morbidity associated with current therapies.
Limits
The paper is a narrative review rather than a systematic review or primary clinical study, and the abstract includes no original experimental data, sample sizes, or quantitative risk estimates.
Cited by
- supports Endometriotic lesions develop increased vascularity and grow nerve fibers around each lesion.